Stephen Barat, Senior VP of Therapeutics at HTG MOLECULAR DIAGNOSTICS, INC (HTGM), sold 888 shares at $0.80 ($710) on 2023-06-08, disclosed to the SEC on 2023-06-09.
Open-market sale of $710 HTGM by Senior VP of Therapeutics. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.